Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 447079)

1.

Hormones and heart disease.

Kent S.

Geriatrics. 1979 Jun;34(6):97-102.

PMID:
447079
2.

Sex hormones and cardiovascular risk.

La Vecchia C.

Hum Reprod. 1992 Feb;7(2):162-7. Review.

PMID:
1577926
3.

Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?

LaRosa JC.

Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3.

PMID:
1617306
4.

Myocardial infarction in women.

Johansson S, Vedin A, Wilhelmsson C.

Epidemiol Rev. 1983;5:67-95. Review.

PMID:
6357823
5.

[Cardiovascular risk factors and prevention in women: similarities and differences].

Sclavo M.

Ital Heart J Suppl. 2001 Feb;2(2):125-41. Review. Italian.

PMID:
11255880
6.

Cholesterol, lipoproteins, and coronary heart disease in women.

Bush TL, Fried LP, Barrett-Connor E.

Clin Chem. 1988;34(8B):B60-70. Review.

PMID:
3042201
7.
8.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
9.

Sex hormones and coronary disease: a review of the clinical studies.

Kalin MF, Zumoff B.

Steroids. 1990 Aug;55(8):330-52. Review.

PMID:
2237942
10.

Noncontraceptive estrogen use and cardiovascular disease.

Bush TL, Barrett-Connor E.

Epidemiol Rev. 1985;7:89-104. Review.

PMID:
2996919
11.

Women, lipoproteins and cardiovascular disease risk.

LaRosa JC.

Can J Cardiol. 1990 May;6 Suppl B:23B-29B. Review.

PMID:
2188715
12.

[Differences and similarities in ischemic heart disease in men and women].

Piwowarska W, ZyliƄska M.

Folia Med Cracov. 1991;32(1-2):43-56. Review. Polish.

PMID:
1843699
13.

Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community.

Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C.

Am J Epidemiol. 1988 Sep;128(3):606-14.

PMID:
3414664
14.

A prospective study of postmenopausal estrogen therapy and coronary heart disease.

Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH.

N Engl J Med. 1985 Oct 24;313(17):1044-9.

PMID:
4047106
15.

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.

Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE, et al.

Circulation. 1995 Apr 1;91(7):1952-8.

16.

Benefit/risk of estrogen therapy in cardiovascular disease: current knowledge and future challenges.

Chow MS.

J Clin Pharmacol. 1995 Sep;35(9 Suppl):11S-17S. Review.

PMID:
8530712
17.

Oestrogens and the heart.

Rosano GM, Panina G.

Therapie. 1999 May-Jun;54(3):381-5. Review.

PMID:
10500455
18.

Dyslipoproteinemia in women and the elderly.

LaRosa JC.

Med Clin North Am. 1994 Jan;78(1):163-80. Review.

PMID:
8283929
19.

Menopause and risk of cardiovascular disease: the Framingham study.

Kannel WB, Hjortland MC, McNamara PM, Gordon T.

Ann Intern Med. 1976 Oct;85(4):447-52.

PMID:
970770
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk